ArticleAmerican journal of cancer research2020

MY-5445, a phosphodiesterase type 5 inhibitor, resensitizes ABCG2-overexpressing multidrug-resistant cancer cells to cytotoxic anticancer drugs.

Chung-Pu Wu et al.PubMed ↗Full text ↗

No numbers read from the abstract.